/TCHBF

TCHBF Stock - Tecan Group AG

Q: What is the analyst price target for TCHBF?

Analyst price target information is not currently available for TCHBF.

Q: What is TCHBF's market cap?

Market capitalization information is not currently available for TCHBF.

Healthcare|Medical - Instruments & Supplies|OTC

$160.35+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $176.39

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for TCHBF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.28

52W High$230.72

52W Low$155.25

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$934.28M	$1.07B	$1.14B	$946.62M	$730.88M
Gross Profit	$320.60M	$390.47M	$438.07M	$408.57M	$354.92M
Gross Margin	34.3%	36.3%	38.3%	43.2%	48.6%
Operating Income	$75.57M	$135.97M	$147.84M	$145.52M	$121.39M
Net Income	$67.66M	$132.07M	$121.13M	$121.66M	$103.69M
Net Margin	7.2%	12.3%	10.6%	12.9%	14.2%
EPS	$5.30	$10.30	$9.53	$9.95	$8.69

Company Overview

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.

Visit Website

Earnings History & Surprises

TCHBF

Beat Rate

10%

Last 10 quarters

Avg Surprise

-22.1%

EPS vs Estimate

Beats / Misses

1/9

Last 12 quarters

Latest EPS

$1.77

Q3 2025

EPS Surprise History

Q4 21

-11.2%

$5.40vs$6.08

Q2 22

-5.1%

$5.38vs$5.67

Q4 22

-32.3%

$4.67vs$6.90

Q2 23

-25.6%

$4.64vs$6.24

Q1 24

+4.8%

$7.18vs$6.85

Q3 24

-60.5%

$1.95vs$4.94

Q1 25

-3.5%

$3.89vs$4.03

Q3 25

-44.0%

$1.77vs$3.16

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Mar 10, 2026	—	—	—	—
Q3 2025	Aug 12, 2025	$3.16	$1.77	-44.0%	✗ MISS
Q1 2025	Mar 10, 2025	$4.03	$3.89	-3.5%	✗ MISS
Q3 2024	Aug 13, 2024	$4.94	$1.95	-60.5%	✗ MISS
Q1 2024	Feb 27, 2024	$6.85	$7.18	+4.8%	✓ BEAT
Q2 2023	Jun 30, 2023	$6.24	$4.64	-25.6%	✗ MISS
Q4 2022	Dec 31, 2022	$6.90	$4.67	-32.3%	✗ MISS
Q2 2022	Jun 30, 2022	$5.67	$5.38	-5.1%	✗ MISS
Q4 2021	Dec 31, 2021	$6.08	$5.40	-11.2%	✗ MISS
Q2 2021	Jun 30, 2021	$6.55	$5.35	-18.3%	✗ MISS
Q4 2020	Dec 31, 2020	—	$4.87	—	—
Q2 2020	Jun 30, 2020	—	$4.56	—	—
Q4 2019	Dec 31, 2019	$4.19	$3.13	-25.3%	✗ MISS
Q2 2019	Jun 30, 2019	—	$3.13	—	—

Frequently Asked Questions about TCHBF

What is TCHBF's current stock price?

Tecan Group AG (TCHBF) is currently trading at $160.35 per share. The stock has moved +0.00% today.

What is the analyst price target for TCHBF?

No analyst price targets are currently available for this stock.

What sector is Tecan Group AG in?

Tecan Group AG operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.

What is TCHBF's market cap?

Tecan Group AG has a market capitalization of $2.04 billion, making it a mid-cap company.

Does TCHBF pay dividends?

No, Tecan Group AG does not currently pay a dividend to shareholders.